Table 3.
Sampling method | Age group (condition) | Initial cell number | Subculturing method | Success rate in propagation | References |
---|---|---|---|---|---|
Induced sputum | Children | < 2000 cells/ portion | CRC HAE mono (Rho/SMAD inhibition) | 20% in CF patients | Mou et al. [71] |
Tracheal aspirate | Neonatal | < 100 cells/ aspirate | CRC HAE mono (Rho/SMAD/mTOR inhibition) | 40% from single sample, 80% if multiple samples/ patient | Lu et al. [74] |
BAL | Neonatal | < 2000 cells/ portion | CRC HAE, mono (Rho/SMAD inhibition) | 100% (multiple samples/ patient) | Mou et al. [71] |
Nasal brushing | N/A (CF or healthy) | 0.4 to 1.5 million viable cells | Traditional ALI culture |
Culture initiation: CF patients—66%; healthy—85% Differentiation in ALI: 100% |
Schogler et al. [78] |
Bronchial brushing | N/A | 0.045 – 0.2 mln cells/ brush | Indirect CRC HAE co-culture: HAE cells cultured with conditioned fibroblast medium with ROCKi | N/A | Wolf et al. [65] |
Bronchial brushing (non-bronchoscopic) | Children (healthy or asthmatic) | ~ 2,67 mln cells/ 2 brush passes | CRC HAE co-culture, direct | N/A | Martinovich et al. [50] |
BAL Bronchioalveolar lavage, CRC HAE mono conditionally reprogrammed human airway epithelial monoculture (without feeder cells), CRC HAE co-culture conditionally reprogrammed human airway epithelial co-culture (with feeder cells)